MICHAEL MONACO: Open Payments
NPI 1942263215 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 23 payments from 11 companies in 2025. Trend: 2023 $20 · 2024 $596 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $79 |
| Phathom Pharmaceuticals, Inc. | 4 | $79 |
| ABBVIE INC. | 4 | $76 |
| Lilly USA, LLC | 3 | $55 |
| TOLMAR, INC. | 2 | $36 |
| Abbott Laboratories | 1 | $27 |
| Kowa Pharmaceuticals America, Inc. | 1 | $27 |
| Electromed, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $16 |
| Antares Pharma, Inc. | 1 | $15 |
Products named: Ozempic, VOQUEZNA, UBRELVY, MOUNJARO, JATENZO, FREESTYLE LIBRE 3, ZORYVE, SMARTVEST.
Industry payments across KS — which companies pay providers there.
